UPXI 250221 2.50C (UPXI250221C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

UPXI250221C2500

Watchlist

0.05
0.000.00%

15min DelayTrading Oct 2 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Upexi Regains Compliance With Nasdaq
TipRanksDec 23 09:15 ET
Upexi | 10-Q: Q1 2025 Earnings Report
SECDec 19 17:35 ET · Announcements
Upexi | 10-K: FY2024 Annual Report
SECDec 16 17:28 ET · Announcements
Investors Await Jobless Claims Data as Markets Tread Water in Thursday's Premarket
MT NewswiresDec 5 08:13 ET
Mangoceuticals, Inc. Initiates Investigation Into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
GlobeNewswireDec 4 07:00 ET
What's Going On With Upexi Shares Monday?
BenzingaNov 25 14:59 ET

Comments

Mcsnacks H Tupack

4 hours ago

Getting close to where it can run

$Upexi (UPXI.US)$ Bottom is at 3.48 or 3.00. Im thinking 3.48 due to previous price action.

Vincentkit

6 hours ago

$Upexi (UPXI.US)$ still looking

$Upexi (UPXI.US)$
👀

Upexi Regains Compliance with NASDAQ

$Upexi (UPXI.US)$

Jaguar8

Nov 25 22:28

MY WATCHLIST TUESDAY (November 26). Trade the Chart. Don’t open position impulsively.

I WILL UPDATE IF I FIND MORE
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...

Bitcoin's violent fluctuations: the entry point before Trump took office?